darunavir has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leonis, G; Mavromoustakos, T; Megariotis, G; Papadopoulos, MG; Supuran, CT; Tzoupis, H | 1 |
| Ferenci, T; Gerlei, Z; Horváth, G; Kormos, L; Makara, M; Rupnik, Z; Sulyok, M; Szlávik, J; Újhelyi, E; Vályi-Nagy, I | 1 |
2 other study(ies) available for darunavir and Diabetes Mellitus
| Article | Year |
|---|---|
Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations.
Topics: Acquired Immunodeficiency Syndrome; Diabetes Mellitus; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hydrogen Bonding; Hypertension; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Renin; Sodium-Glucose Transporter 2 Inhibitors; Thermodynamics | 2012 |
Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.
Topics: Adult; Aged; Body Mass Index; CD4-CD8 Ratio; Cholesterol; Cross-Sectional Studies; Darunavir; Diabetes Mellitus; Elasticity; Elasticity Imaging Techniques; Fatty Liver; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypertension; Male; Middle Aged; Prevalence; Survivors; Time Factors; Triglycerides; Young Adult | 2015 |